Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | PYGB | P11216 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | GBA1 | P04062 | 2/20 | 0.43 |
| ▸ | CETP | P11597 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL28220533 | 0.96 | MAPK1 (0.44) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Docosanol SCHEMBL5427356 | 0.94 | LMNA (0.48) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Beta-D-Glucose SCHEMBL28846276 | 0.91 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Dextrose SCHEMBL28152748 | 0.91 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Dextrose SCHEMBL28275408 | 0.91 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Beta-D-Glucose SCHEMBL8171439 | 0.91 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Dextrose SCHEMBL28318841 | 0.91 | MAPK1 (0.41) | MAPK1LGALS1LGALS3LGALS9LGALS8 | |
| Dextrose SCHEMBL4966899 | 0.88 | CETP (0.43) | GAAGBA1CETP | |
| Dextrose SCHEMBL3681561 | 0.88 | PRKD3 (0.50) | MAPK1PYGBCETP | |
| B-D-Galactose SCHEMBL28470620 | 0.87 | LGALS1 (0.52) | LGALS1LGALS3LGALS9LGALS8PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3078365-B1 | SOLUBILIZING AGENTS AND AQUEOUS COMPOSITIONS COMPRISING THEM | DAITO KASEI IND FRANCE (FR) | 2020-03-04 | — | — | EP | claimed |
| EP-4282944-A1 | UNIT DOSE FOR PERSONAL CARE OR HOUSEHOLD CARE COMPOSITION | Dalli-Werke GmbH & Co. KG (DE) | 2023-11-29 | — | — | EP | disclosed |
| EP-4098326-A1 | UNIT DOSE FOR COSMETIC COMPOSITION COMPRISING AN EFFERVESCENT SYSTEM | Dalli-Werke GmbH & Co. KG (DE) | 2022-12-07 | — | — | EP | disclosed |
| EP-3873682-B1 | CLEANING OF INDUSTRIAL COMPONENTS | INDUSCLEAN NV (BE) | 2022-06-15 | — | — | EP | disclosed |
| EP-3873682-A1 | CLEANING OF INDUSTRIAL COMPONENTS | INDUSCLEAN Naamloze Vennootschap (BE) | 2021-09-08 | — | — | EP | disclosed |
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | CYPRUMED GMBH (AT) | 2021-02-02 | — | — | US | disclosed |
| EP-3246013-B1 | INHIBITION OF THE ADHESION OF PATOGENIC MICROORGANISMS BY POLYSORBATE 20 IN THE COSMETIC TREATMENT OF ATOPIC DERMATITIS | THOREL JEAN NOEL (FR) | 2019-10-09 | — | — | EP | disclosed |
| US-20180280481-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | CYPRUMED GMBH (AT) | 2018-10-04 | — | — | US | disclosed |
| US-20180258370-A1 | ETHANOL-FREE, AQUEOUS MICROEMULSION PERFUME COMPOSITIONS | SOLINAS SYLVAIN (GB) | 2018-09-13 | — | — | US | disclosed |
| EP-2359800-B1 | Composition for cosmetic treatment of keratin fibres comprising volatile linear alkanes, C8-30 fatty alcohols and mono- or polyglycosides | OREAL (FR) | 2018-09-12 | — | — | EP | disclosed |
| EP-2097059-B1 | CLEANSING OR CARE PRODUCT | HENKEL KGAA (DE) | 2012-04-18 | — | — | EP | disclosed |
| EP-2359800-A2 | Composition for cosmetic treatment of keratin fibres comprising volatile linear alkanes, C8-30 fatty alcohols and mono- or polyglycosides | L'Oréal (FR) | 2011-08-24 | — | — | EP | disclosed |
| EP-2097059-A1 | CLEANSING OR CARE PRODUCT | Henkel Kommanditgesellschaft auf Aktien (DE) | 2009-09-09 | — | — | EP | disclosed |
| EP-1776078-B1 | SELF-FOAMING WASHING SACHETS | HENKEL AG & CO KGAA (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2008065072-A1 | CLEANSING OR CARE PRODUCT | HENKEL AG & CO. KGAA (DE) | 2008-06-05 | — | — | WO | disclosed |
| EP-1901703-A1 | SKIN-LIGHTENING COMPOSITIONS WITH AN IMPROVED ACTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1776078-A1 | SELF-FOAMING WASHING SACHETS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-04-25 | — | — | EP | disclosed |
| WO-2007003289-A1 | SKIN-LIGHTENING COMPOSITIONS WITH AN IMPROVED ACTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-11 | — | — | WO | disclosed |
| WO-2006018137-A1 | SELF-FOAMING WASHING SACHETS | HANS SCHWARZKOPF & HENKEL GMBH & CO. KG (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-20040063033-A1 | Press life and an excellent scum resistance during printing | FUJI PHOTO FILM CO., LTD. | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180280481-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | SLC30A5, SLC39A11, SLC30A6 | MAPK1 2655/4885LGALS1 1893/4885LGALS3 2077/4885 |
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | SLC30A5, SLC39A11, SLC30A6 | MAPK1 2655/4885LGALS1 1893/4885LGALS3 2077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.